Evidence map›Paper›PMID 41823379›Full record

ArticleMicrobiology resource announcements2026

Whole-genome sequence of an extensively drug-resistant

Cheickna Hamallah Dicko, Ibrehima Guindo, Mohamed Ag Baraika, Ousmane Kamena, Noumou Yakhouba Keita, Demba Koita, Alhadji Dicko, Mahamadou Abdou, Klema Marcel Kone, Aissata Boubakar Cisse and 2 more

Abstract read
In one paragraph

Article in Microbiology resource announcements, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cheickna Hamallah Dicko *Research Laboratory of Microbiology Infectious Diseases, Allergology and Pathogen Surveillance (LARMIAS), Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.ORCID 0009-0005-1729-7685
Ibrehima Guindo *National Institute of Public Health, Bamako, Mali.
Mohamed Ag BaraikaNational Institute of Public Health, Bamako, Mali.
Ousmane KamenaNational Institute of Public Health, Bamako, Mali.
Noumou Yakhouba KeitaNational Institute of Public Health, Bamako, Mali.
Demba KoitaNational Institute of Public Health, Bamako, Mali.
Alhadji DickoNational Institute of Public Health, Bamako, Mali.
Mahamadou AbdouNational Institute of Public Health, Bamako, Mali.
Klema Marcel KoneNational Institute of Public Health, Bamako, Mali.
Aissata Boubakar CisseNational Institute of Public Health, Bamako, Mali.
Rihab FestaliResearch Laboratory of Microbiology Infectious Diseases, Allergology and Pathogen Surveillance (LARMIAS), Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.
Idrissa DiawaraResearch Laboratory of Microbiology Infectious Diseases, Allergology and Pathogen Surveillance (LARMIAS), Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.ORCID 0000-0003-4122-2294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacterantibiotic resistancebioinformaticsgenomicsMaliOxford Nanopore TechnologiesWGS

Identifiers

PMID41823379
PMCPMC13063947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.